Hepatic steatosis and advanced fibrosis are independent predictors of mortality in acute myocardial infarction without standard modifiable risk factors
出版年份 2022 全文链接
标题
Hepatic steatosis and advanced fibrosis are independent predictors of mortality in acute myocardial infarction without standard modifiable risk factors
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-07-18
DOI
10.1111/dom.14820
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A global view of the interplay between non-alcoholic fatty liver disease and diabetes
- (2022) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
- (2022) Jingxuan Quek et al. Endocrine Practice
- Global Prevalence and Clinical Characteristics of Metabolic Associated Fatty Liver Disease. A Meta-Analysis and Systematic Review of 10,739,607 Individuals
- (2022) Kai En Chan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients
- (2022) Gwyneth Kong et al. Frontiers in Cardiovascular Medicine
- Non-Alcoholic Steatohepatitis Drug Development Pipeline: An Update
- (2022) Nicholas Chew et al. SEMINARS IN LIVER DISEASE
- Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
- (2021) Luca Rinaldi et al. Antioxidants
- Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
- (2021) Ferdinando Carlo Sasso et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study
- (2020) Luigi Elio Adinolfi et al. ATHEROSCLEROSIS
- Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
- (2020) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Causes, consequences, and treatment of metabolically unhealthy fat distribution
- (2020) Norbert Stefan Lancet Diabetes & Endocrinology
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
- (2019) Stephen T. Vernon et al. Journal of the American Heart Association
- Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
- (2017) Cristina Alonso et al. GASTROENTEROLOGY
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation